MSFT 1Q20 Earnings

Current Price: $139 Price Target: $150

Position size: 6.3% TTM Performance: 38%

Microsoft reported solid Q1 results, beating street high estimates on both revenue and EPS. Street is at the high end of Q2 guidance. The beat was broad based with better than expected growth in all segments. Cloud continues to be the key driver. Q1 revenue was $33B (+14% YoY) and EPS was $1.38 (+21%). Commercial Cloud business was up 39% constant currency and saw continued margin improvement, helping to drive op income up 27%. Counted w/in that is Azure, which was up 63% constant currency. They are taking share from Amazon’s cloud offering, AWS. This should continue as they are better positioned as more large enterprises, that are longtime customers, move to the cloud. Given their enterprise customer base, recent partnerships with SAP, VMware and Oracle, and superior Azure hybrid architecture, the company is uniquely positioned to capitalize on the growing demand for cloud services.

Key Takeaways:

· FY 2020 revenue guided to up double-digits and op margins are expected to increase slightly.

· Solid growth across all 3 segments:

o Productivity & Business Processes, up 13% YoY, $11.1B – driven by strong performance in Office commercial and LinkedIn

o Intelligent Cloud, up 27% YoY, $10.8B – driven by continued strong growth in Azure

o More Personal Computing, up 4% YoY, $11.1B.

· Q1 Commercial Cloud (consisting of O365 Commercial, Azure, Dynamics Online, and LinkedIn Commercial – this includes some revenue from the first two segments above) was $11.6B, up 39% constant currency in the quarter.

· Within Commercial Cloud, Azure growth was +63% YoY constant currency vs. +68% last quarter. That suggests annualized revenue of ~$17B.

· Recently announced partnership with SAP makes Azure the preferred destination for every SAP customer.

· Commercial Cloud gross margins improved 400bps YoY and 100bps sequentially, driven by material improvement in Azure gross margin. Incremental cloud revenues have very high margins and should continue to drive margin expansion.

· Surface Duo – new Android-based dual-screen phone to be available next fall. Could be a promising re-entry into phone space after epic Nokia failure, but w/ Android OS instead of Windows.

Valuation:

· Trading at a 3-4% FCF yield –still reasonable for a company with double digit top line growth, high ROIC and a high and improving FCF margins.

· They easily cover their 1.5% dividend, which they have been consistently growing.

· Strong balance sheet with about $137B in gross cash, and about $51B in net cash.

Investment Thesis:

· Industry Leader: Global monopoly in software that has a fast growing and underappreciated cloud business.

· Product cycle tailwinds: Windows 10 and transition to Cloud (subscription revenues).

· Huge improvements in operational efficiency in recent quarters providing a significant boost to margins which should continue to amplify bottom line growth.

· Return of Capital: High FCF generation and returning significant capital to shareholders via dividends and share repurchases.

$MSFT.US

[tag MSFT]

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

Hilton 3Q19 Results

Share Price: $94 Target Price: $105

Position Size: 2.8% 1 Yr. Return: 33%

Hilton beat on revenue and EPS, but lowered RevPAR guidance as global macro trends weaken. Despite that, EPS guidance was increased, demonstrating the strength of their asset light business model and strong unit growth. Given their robust development story, they are a lot less dependent on macro driven RevPAR. Their development pipeline is delivering 6-7% unit growth. On 0.4% RevPAR growth in 3Q, they grew EBITDA 9%. Additionally, their pipeline growth is not slowing and has some countercyclical aspects. They plan to return $1.6-$1.8B in capital to shareholders for the year (they’ve returned $1.2B so far), equating to ~7% of their market cap.

Key takeaways:

· System-wide RevPAR of 0.4%, driven by both ADR and occupancy.

· Full year RevPAR guidance lowered to 1% from 1-2% as their broad macro outlook has weakened.

· Saw softness in the US and Asia Pacific. US was +0.4% and Asia Pacific was -2.7% driven by weakness in China. China RevPAR was -5.6% – This includes impact from Hong Kong protests, where RevPAR was down 40%. Mainland China was down <3%.

· Issued 2020 RevPAR guidance of 0% to +1%. Expect 2020 net unit growth of 6-7% range.

· During the quarter they completed the sale of the Hilton Odawara Resort & Spa and subsequently entered into a 30-year management contract with the purchaser of the hotel.

· Solid net unit growth continues to drive strong performance. Pipeline of 379K rooms (>2,500 hotels throughout 111 countries). Over 200K of these hotels are outside the US and more than 50% are already under construction.

· Current pipeline represents close to 40% unit growth. With expected annual growth of about 6%, their pipeline is several years’ worth of growth with about half of it already under construction. More than 90% of their deals do not require any capital from them.

· Continued improvement in their market leading RevPAR index – RevPAR index is RevPAR premium/discount relative to peers adjusted for chain scale. They are the market leaders – this is helpful because it’s what leads to pipeline growth (hotel operators want to associate w/ the brand that yields the best rates and occupancy) and is helpful in a macro downturn because it’s even more crucial for a developer to be associated with a market leading brand to get financing. i.e. they would likely take more pipeline share if lending standards tighten. The other countercyclical aspect of their pipeline growth is conversions (an existing hotel changes their banner to Hilton).

· Tru is a fast growing new brand for them which management says has the opportunity to be much bigger than Hampton Inn. Hampton Inn is their largest brand with over 250K rooms. Demonstrating the strength in both new and existing brands: Tru has a RevPAR index of 130 (the highest brand premium in the industry) and Hampton (35 year old brand) has a RevPAR index of 120 – and a pipeline of more than 700 hotels.

· In a sensitivity analysis to a market downturn, mgmt. said they would expect flat to slightly positive growth in adjusted EBITDA and positive growth in free cash flow in an environment where RevPAR were to decline 5% to 6%. This is b/c Hilton is structurally different than it was last cycle – asset light means less operating leverage and less volatile earnings stream if RevPAR continues to weaken. Moreover, unit growth will aid EBITDA growth regardless of RevPAR trends.

· Loyalty members hit 99m and account for >60% of system-wide occupancy.

· The stock is undervalued, trading at ~6% FCF yield on 2020.

Investment Thesis:

∙ Hotel operator and franchiser with geographic and chain scale diversity of 17 brands, 5,900 hotels and 939k rooms across 114 countries (Hilton, DoubleTree, Hampton Inn & Hilton Garden Inn ≈ 80% of portfolio).

∙ Network effect moat of leading hotel brand and global scale lead to room revenue premiums and lower distribution costs.

∙ Shift from hotel ownership to franchising results in resilient, asset-light, fee-based model.

∙ Record pipeline generating substantial returns on minimal capital will lead to increasing ROIC and a higher multiple.

∙ Unit growth and fee based model reduce cyclicality – Lower operating leverage vs ownership reduces earnings volatility and unit growth offsets potential room rate weakness.

∙ Generating significant cash which is returned to shareholders through dividends and buybacks.

$HLT.US

[tag HLT]

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

SHW 3Q19 Update

Current Price: $564 Price Target: Increasing to $660 from $540

Position Size: 3.7% TTM Performance: +38%

SHW beat on revenue and EPS and increased the midpoint of guidance (implies +14% YoY EPS growth). The America’s group again had impressive paint stores SSS performance of +8%. Gross margins continue to improve as recent pricing actions are gaining traction to offset raw material inflation. Performance in the quarter was driven by continued strength in North American architectural paint markets, which offset choppiness in some industrial end markets. Management talked positively about housing market strength – despite headline miss reported today in existing home sales which were down sequentially, but still up YoY.

Key Takeaways:

· SHW is benefitting from higher product prices, good volume growth, falling raw material costs and an improvement in housing.

· Margins increased in all 3 segments.

· They continue to see some softness internationally and strength in the US.

· The Americas Group: 55% of sales, +8.7%

o SSS of +8%, an acceleration from +4.3% last quarter.

o Generated strong growth in all regions and all customer end markets, led by double digit growth in residential repaint.

o Opened 31 net new stores year to date.

o Professional painting contractor customers continue to report strong demand.

· Consumer Brands Group: 16% of sales, -12%

o The decrease in the quarter was due to softer sales outside of North America, lapping load-in sales for a new customer program in 2018 and the divestiture of the Guardsman furniture protection business.

o In North America, we continued to strengthen our relationships with our largest retail partners.

o FX headwinds(-1.3%)

· Performance Coatings Group: 29% of sales, -0.3%

o Soft sales outside North America and unfavorable currency translation. FX headwinds(-1.6%)

o The segment was impacted by slowing industrial demand in some end markets, leading to slightly lower sales in the quarter.

o Despite the softer than expected top line, with moderating raw material costs margins increased YoY.

o Revenue growth strongest in coil and packaging.

Valuation:

  • Expected free cash flow of ~$2.2B in 2020, trading at >4% FCF yield.
  • Given growth prospects, steady FCF margins and high ROIC the stock is undervalued. They deserve a premium multiple based on large exposure to the N. American paint contractor market and lack of exposure to the cyclical sensitive auto OEM end market.
  • Balance sheet leverage from the Valspar acquisition continues to improve; they expect to get to under 3x by the end of the year.

· Refinanced and extended the maturity of their debt, locking in lower rates.

· Share buybacks should increase in 2020 as they get their leverage ratio down to 2-3x.

Thesis:

  • SHW is the largest supplier of architectural coatings in the US. Sherwin-Williams has the leading market share among professional painters, who value brand, quality, and store proximity far more than their consumer (do-it-yourself) counterparts.
  • Their acquisition of Valspar creates a more diversified product portfolio, greater geographic reach, and is expected to be accretive to margins and EPS. The combined company is a premier global paint and coatings provider.
  • SHW is a high-quality materials company leveraged to the U.S. housing market. Current macro and business factors are supportive of demand:
    • High/growing U.S. home equity values. Home equity supportive of renovations.
    • Improving household formation rates off trough levels (aging millennials).
    • Baby boomers increasingly preferring to hire professionals vs. DIY.
    • Solid job gains and low mortgage rates support homeownership.
    • Residential repainting makes up two thirds of paint volume. Homeowners view repainting as a low-cost, high-return way of increasing the value of their home, especially before putting it on the market.

$SHW.US

[tag SHW]

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

Crown Castle Earnings Update

Crown Castle reported a good quarter yesterday with a broad beat and strong guidance. CCI beat on both site rental revenue and networks services revenue, and reported better than expected EBITDA and EPS.

Thesis intact, highlights on the quarter:

· The company is experiencing the highest level of tower leasing activity in more than a decade, and management expects this to continue.

· Organic site rental revenue was +6%

· CCI small cell pipeline in 2019 is 10 – 15 thousand nodes (trending now on the lower end around 10k)

· Management provided FY20 guidance for the first time for ~8% AFFO growth and assumes the proposed merger between T-Mobile and Sprint in 1Q20

· Strong 2020 outlook for new leasing activity for towers: +$145 million at the mid-point is $5 million higher than +$140m outlook for 2019.

· Fiber guidance reflects an expectation for improved leasing activity. Initial outlook for new leasing activity in 2020 of $165 million is +$15 million higher than the company’s 2019 outlook for $150 million in fiber solutions.

· CCI’s outlook on fiber and small cells reflects carriers’ deployment of new spectrum and densification of their networks in preparation for 5G

· Big 4 carriers make up 90% of site rental revenue – AT&T, Sprint, T-Mobile and Verizon.

· Could see churn picking up from the TMUS/S merger in 2020. However, management views a T-Mobile/Sprint merger as a long-term positive as Sprint has valuable spectrum holdings which it has not been able to fully deploy due to capital constraints, and T-Mobile appears likely to accelerate deployment of 5G as part of its anticipated integration. Management believes that the investment from a combined T-Mobile/Sprint, with or without DISH as a fourth wireless carrier, will likely more than offset the impacts of T-Mobile decommissioning duplicative sites.

· Dividend increase of 7% delivered on targeted annual range of 7-8%.

Valuation:

· Strong AFFO growth will drive the valuation (2020 expected 8% YoY). They have a 10 year AFFO CAGR of ~14%.

· High incremental margins means AFFO growth should outpace or be in line with site rental revenue growth.

· Low maintenance capex (~2% of revenue) supports high AFFO margins.

· Expected $2.479B in AFFO ($5.94/share) in 2019 is a yield of just under 5%. This is an attractive yield given the secular growth potential.

The Thesis on Crown Castle:

1. CCI is well positioned to capitalize on secular mobile data demand growth and small cell/urban opportunity.

2. Strong competitive position. Leading US tower company.

3. Toll booth business – offensive (secular growth) & defensive (4% dividend & contracted cash flows) characteristics.

4. Revenues derived from long term contracts with price escalators and good visibility.

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

$CCI.US

[tag CCI]

JNJ 3Q19 earnings summary

Key Takeaways:

Current Price: $133 Price Target: $150

Position size: 2.52% 1-Year Performance: -2.4%

J&J reported sales and earnings ahead of expectations, thanks to better pharma drug sales of +6.4% organic. The Medical Devices segment saw good growth as well (+5.3% organic), while Consumer was the lowest reported (+1.3% organic) due to tough comps y/y and competitive pressure outside the US. On the positive side, the beauty and OTC businesses continue to gain market share in the US. JNJ raised its 2019 sales and EPS guidance after today’s results: organic sales now expected to be +4.5%-5% (from +3.2%-3.7%) and EPS 1% higher. China is still experiencing healthy growth (15% overall): 19% from Medical Devices, 14% in Pharma, 5% in Consumer. Tariffs had no impact on the business.

The company gave a preliminary 2020 outlook: sales growth to reaccelerate thanks to above market growth in Pharma and consistent Medical Devices growth of 3-4%. EPS growth will be somewhat limited by investment in R&D, especially in Medical Devices.

During the call, the management team answered some questions on recent litigation matters. They see the talc litigation as a big business for plaintiffs’ attorney, who spent $400M in TV advertising trying to add new class action suits. This has become a $36B industry, looking for negative headlines to drive more plaintiffs. The management team added that judgments in their favor rarely make the headlines. However, J&J has not seen any negative impacts from the lawsuits on their consumer segment, and will continue to defend its products. Regarding opioids, it seems the company is willing to settle (rather than go to court), as its sees this as the better solution for all stakeholders.

Thesis on JNJ reiterated:

  • High quality company with consistent 20% ROE, attractive FCF yield,
  • Investments in the pipeline and moderating patent expirations create a profile for accelerated revenue and earnings growth
  • Growth opportunity: Medical Devices and Consumer offer sustainable growth and potential for expansion internationally
  • Strong balance sheet that offers opportunities for M&A.

[tag JNJ]

$JNJ.US

Julie S. Praline

Director, Equity Analyst

Direct: 617.226.0025

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

Constellation Brands (STZ) earnings summary

Key takeaways:

Current Price: $192 Price Target: $226 (NEW)

Position Size: 2.52% 1-Year Performance: +15.5% (since inception 12/20/2018)

Constellation Brands released their 2Q FY20 earnings results this morning. While their beer performance was stellar as usual (+7.5% depletion), it was overshadowed by their cannabis investment. Canopy Growth proves to be more challenging, with close to $500M in losses this quarter, and STZ recognizing a $839M decrease on its equity fair value. This is not totally surprising as STZ ousted Canopy’s founder and CEO Bruce Linton this summer, being “not pleased” with Canopy’s results, announcing this summer that they needed 3-5 year to turn profitable.

The FY20 guidance of 7-9% beer sales and operating income growth was maintained, while its wine sales decline is now better at -15% to -20% (vs. prior -20% to -25%). The divestment of the lower-priced wines is now expected to close at the end of 3Q FY20, explaining why the adjusted sales and EPS guidance was raised slightly to account for a later divestment date than expected. Gross margins expanded 45bps.

We are excited to hear that Constellation is expanding its Corona line with the launch of a Corona Hard Seltzer next year (a high growth drink category). We are updating our price target to $226 to account for the sale of the lower priced wine & spirit brands (lowering FCF $).

Below is a picture of the new product (not yet released by the company – this was found on a blog…)

Investment Thesis:

· Adding STZ helps position our portfolio to be more defensive at this stage of the economic cycle

· STZ is down ~20% YTD, giving us a good entry point

· STZ continues to have HSD top line growth and high margins that should incrementally improve going forward

· STZ comes out of a heavy capex investment cycle to support its growth: FCF margins are set to inflect thanks to lower capex

[tag STZ]

$STZ.US

Julie S. Praline

Director, Equity Analyst

Direct: 617.226.0025

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

Schwab cuts trading fees to zero

Hi,

Yesterday Schwab announced that they would eliminate commissions on trades for all US stocks and ETFs. The surprise move sent SCHW shares down 10% and sent ripples across other online trading companies. For Schwab trading revenue has been declining for the past decade. They advertise discount trading to grow assets under management (AUM). They have been the leader in reducing costs and pressuring the competitors to follow.

For Schwab trading revenue is only 6-7% of total revenue which is far less than Ameritrade or IBG both whom collect more than a third of their revenue from trading. Clearly, Schwab is placing a lot of pressure on competitors and some consolidation is expected. Yesterday, Ameritrade’s stock fell by over 20%.

Our thesis for buying Schwab focuses on growth in AUM, not trading revenue. Schwab estimates they could lose $400m in revenue through zero commissions which could be replaced by $20b gain in deposits. Schwab has grown deposits by more than $20b annually over the past 3 years. Deposit growth is driven by AUM growth and the amount of cash held by investors. Cash levels are near market cycle lows, so an increase in market volatility (fear) could raise cash levels and benefit Schwab’s bottom line.

Since we bought Schwab, interest rates have fallen significantly. Considering Schwab’s interest revenue is 73% of total revenue, the effect of a decline in interest rates on net margin is important – much more important than trading revenue. We expect some contraction in net interest margin, but also expect Schwab to manage costs by keeping deposit yields low. Schwab’s strategy to gain assets is to give away trading, while Fidelity has been advertising higher yields on money markets funds.

Schwab reports Q3 on 10/15, which will give us greater insight on AUM growth, deposit growth and net interest margin.

Please let me know if you have any questions.

Thanks,

John

$US.SCHW

[tag Equity Research]

John R. Ingram CFA

Chief Investment Officer

Partner

Direct: 617.226.0021

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

McCormick (MKC) 3Q19 earnings review

Key Takeaways:

Current Price: $167 Price Target: $174 (NEW)

Position size: 2.80% 1-Year Performance: +26%

McCormick released 3Q EPS that beat expectations with sales +2.2% (ex-FX), thanks to positive volume/mix in its Consumer segment: sales were +4%. Consumer operating margins expanded 250bps y/y, leading adjusted consolidated margins higher 160bps y/y. Their Flavor Solutions segment proved once more to be volatile quarter-to-quarter as sales were down 0.4%. The company had a warehouse transition to support its future growth which had a negative impact on sales as well. The management team raised the EPS guidance for the year to $5.30-$5.35 from $5.20-$5.30 but this is mostly driven by lower taxes as sales growth (ex-FX) was narrowed down to 3-4% from 3.5% and operating income from 8-10% to 8-9%. As the reduction in leverage is ahead of schedule, MKC announced being on the hunt for companies to acquire. The company is also expecting to spend more in advertising in the fourth quarter, an important season for the company with the Holidays and home cooking. While the quarter was good, we think the stock is reacting very well today (+7%) as the management team highlighted during the call that the growth in the private label category recently moderated significantly. The competition from private labels has been strong in the past years, so we see this as a good explanation for today’s move back to prior trading levels the stock reached this summer (the stock had been weak after a sell-side analyst downgrade in August). We are updating our price target to $174.

The Thesis on MKC:

• Industry Leader: McCormick & Company (MKC) is a leading manufacturer of spices and flavorings. MKC has been in business for 120 years and the founding family still has ownership interest

• Growth opportunity: Spice consumption is growing 3 times faster than population growth. With the leading branded and private label position, MKC stands to be the biggest beneficiary of this global trend

• Offense/Defense: MKC supplies spices to major food companies including PepsiCo and YUM! Brands giving it a blend of cyclical and counter-cyclical exposure

• Balance sheet and cash flow strength offer opportunities for continued consolidation through M&A in the sector

$US.MKC

[tag MKC]

Julie S. Praline

Director, Equity Analyst

Direct: 617.226.0025

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com